Get started
NOVAVAX INCNOVAVAX INCNOVAVAX INC

NOVAVAX INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Bonds

NVAX trade ideas

Novavax Announces $1.6 Billion Funding from Operation Warp SpeedNovavax Announces $1.6 Billion Funding from Operation Warp Speed has been selected to participate in Operation Warp Speed (OWS), a U.S. government program that aims to begin delivering millions of doses of a safe, effective vaccine for COVID-19 in 2021. Novavax has been awarded $1.6 billion by the federal government to complete late-stage clinical development, including a pivotal Phase 3 clinical trial; establish large-scale manufacturing; and deliver 100 million doses of NVX‑CoV2373, Novavax’ COVID-19 vaccine candidate, as early as late 2020. NVX‑CoV2373 consists of a stable, prefusion protein made using its proprietary nanoparticle technology and includes Novavax’ proprietary Matrix‑M™ adjuvant.
NASDAQ:NVAX
by AlenCiken
1
Nvax to Receive up to $388 Million Funding from CEPI CASE STUDY1. Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing -Funds clinical development of NVX-CoV2373 through Phase 2 -Supports rapid scale-up of vaccine manufacturing -Allows for increased production of Matrix-M adjuvant -Reserves global large-scale manufacturing capacity A Phase 1/2 clinical trial with the Phase I portion starting this month in Australia and the Phase 2 portion conducted in multiple countries following successful Phase 1 top-line results that are expected in July. ir.novavax.com 2. Novavax Reports First Quarter 2020 Financial Results -CEPI increases investment up to $388 million for NVX‑CoV2373 vaccine development & manufacturing -NVX‑CoV2373 Phase I trial initiating in May with preliminary results in July -NanoFlu recently achieved all primary endpoints in pivotal Phase 3 clinical trial ir.novavax.com
NASDAQ:NVAX
by AlenCiken
NVAX: Key Points to Look AtEarlier today, I put a target of at most $115 and later was convinced to do a sell off at $108. Many people thought this would go straight to $150+, but it looks like the positive wedge have peaked. Right now, I currently think the dip will likely be at the $90 price point, but an important factor to consider is closely monitoring movement at the $95 mark. The advanced decline ratio seems to be peaking, and the FIB retracement also showed that it was towards its high point in the morning for the current correlation trend. As always, invest in your own risk and proceed with caution. This is on an opinion based basis.
NASDAQ:NVAXShort
by gamer456148
1
[NVAX] Novavax: Update - 1.6 billion funded!I still believe NVAX has a lot of potential and I'll say it again. My idea is clear that its NanoParticle and Matrix-M Adjuvant tech makes it a prime candidate for a COVID-19 vaccines. Even if it doesn't make it first (or ever), it still has major potential for the seasonal influenza (w/ NanoFlu) and its Respiratory Syncytial Virus (RSV) vaccine. Check out my original post that is linked. Today's News: 1. www.cnbc.com 2. www.fool.com
NASDAQ:NVAXLong
by traderman001
NOVAVAX - long term targetsThese are my thoughts on Novavax. They are meant to give you an idea, not trading advice. As written in the textbooks, gaps in a downtrend always get filled in an uptrend. We already filled gap 1. I believe it's time to start filling gap 2, witch is gigantic. Novavax is receiving a lot of financial support for making a Covid19 vaccin, so expectations are high for now. It's one of the stronger stocks in the market at this moment, working together with Biotechnology. As you can see on the charts, we have formed a similar pattern as we did in April 2020. I don't know how fast gap 2 can get filled, but as soon as we started filing gap 1, things skyrocketed. I'm very excited to see how this will play out, and I hope it can help you. Please note that Novavax is a very volatile stock, things can change very fast over night. Be careful when entering your position in this stock!
NASDAQ:NVAXLong
by AXLP
15
NVAX Long - $150 Target?I've been following NVAX since price was at $12. Fundamentally they have one of the most promising COVID vaccines and their Nano Flu shot beat Sanify's flu shot, whos been a market majority holder in that aspect. Technically, we've tapped that $150+ zone 8 out of the last 9 fast rises over since the company IPO'd in 1996. Each of the rises have been driven by pandemic viruses..ie, swine flu, bird flu, H1N1, etc. We have 4 days until the quarterly candle closes. If we close strong, we'd of closed above the coral, and momentum and RSI are correlating. I think we will see a short term sell off at the psychological $100 level. How much? I could see $80-$85 be a good rebuy zone to push price up to t $125 then $150. Buyers at $80, will probably be looking for a double on their investment which would put price at $160. Let me know what you think!
NASDAQ:NVAXLong
by allout06
7
Novavax (NVAX) stock price is on track...for now [LONG]Just re-iterating my previous assertion (guess) that NVAX is on course for massive gains in the long-term. Doesn't mean it's a great company but this pandemic has initiated a similar pattern in the past. They have several great developments in the works: NanoFlu, RSV F, and a COVID-19 vaccine candidate. See my previous posts especially the related one. This is purely speculation based on their pipeline. This is not financial advice.
NASDAQ:NVAXLong
by traderman001
3